Literature DB >> 1464625

Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro.

J C Fredenburgh1, M E Nesheim.   

Abstract

Plasminogen, the zymogen form of the fibrinolytic enzyme plasmin, is known to undergo plasmin-mediated modification in vitro. The modified form, Lys-plasminogen, is superior to the native Glu-plasminogen in fibrin binding and as a substrate for activation by tissue-type plasminogen activator (t-PA). The present study was undertaken to determine the existence and significance of the Glu- to Lys-plasminogen conversion during t-PA-mediated lysis of plasma clots in vitro. When human plasma was supplemented with exogenous Lys-plasminogen and clotted, a dose-dependent shortening of lysis time was observed. Formation of Lys-plasminogen in situ during fibrinolysis was determined using 131I-Glu-plasminogen-supplemented plasma. By the time of lysis, Lys-plasminogen had accumulated to about 20% of the initial concentration of Glu-plasminogen. Quantitation of activation of both Glu- and Lys-plasminogen as well as the conversion of Glu- to Lys-plasminogen in plasma supplemented with both 131I-Glu-plasminogen and 125I-Lys-plasminogen was accomplished by determining the flux of the isotopically labeled species along three pathways: Glu-plasminogen-->Glu-plasmin, Glu-plasminogen-->Lys-plasminogen, and Lys-plasminogen-->Lys-plasmin. After a brief lag, the Glu-plasminogen activation rate was constant until lysis was achieved, at which point activation ceased. The Lys-plasminogen activation rate also was essentially constant until lysis but was not characterized by a lag phase. The rate of conversion of Glu- to Lys-plasminogen was nonlinear and correlated directly with the rate of fibrinolysis. By the time lysis had occurred, Glu-plasminogen consumption had been distributed equally between direct activation to plasmin and conversion to Lys-plasminogen, and 45% of the plasmin which had been formed was derived from Lys-plasminogen. These results demonstrate both the formation and the subsequent activation of Lys-plasminogen during fibrinolysis. As a result of improved fibrin binding and activation of Lys-plasminogen compared to Glu-plasminogen, the formation of Lys-plasminogen within a clot constitutes a positive feedback mechanism that can further stimulate the activation of plasminogen by t-PA as fibrinolysis progresses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1464625

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  A high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue-type plasminogen activator.

Authors:  Paul Y Kim; Long D Tieu; Alan R Stafford; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2011-12-20       Impact factor: 5.157

2.  Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon.

Authors:  Tanya M Binette; Fletcher B Taylor; Glenn Peer; Laszlo Bajzar
Journal:  Blood       Date:  2007-07-20       Impact factor: 22.113

3.  Kinetics of an autocatalytic zymogen reaction in the presence of an inhibitor coupled to a monitoring reaction.

Authors:  M C Manjabacas; E Valero; M García-Moreno; C Garrido; R Varón
Journal:  Bull Math Biol       Date:  1996-01       Impact factor: 1.758

4.  Skizzle is a novel plasminogen- and plasmin-binding protein from Streptococcus agalactiae that targets proteins of human fibrinolysis to promote plasmin generation.

Authors:  Karen G Wiles; Peter Panizzi; Heather K Kroh; Paul E Bock
Journal:  J Biol Chem       Date:  2010-04-30       Impact factor: 5.157

5.  Human neutrophil elastase mediates fibrinolysis shutdown through competitive degradation of plasminogen and generation of angiostatin.

Authors:  Christopher D Barrett; Hunter B Moore; Anirban Banerjee; Christopher C Silliman; Ernest E Moore; Michael B Yaffe
Journal:  J Trauma Acute Care Surg       Date:  2017-12       Impact factor: 3.313

6.  Kinetics of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)-catalyzed cleavage of C-terminal lysine residues of fibrin degradation products and removal of plasminogen-binding sites.

Authors:  Jonathan H Foley; Paul F Cook; Michael E Nesheim
Journal:  J Biol Chem       Date:  2011-04-05       Impact factor: 5.157

7.  Bacillus anthracis interacts with plasmin(ogen) to evade C3b-dependent innate immunity.

Authors:  Myung-Chul Chung; Jessica H Tonry; Aarthi Narayanan; Nathan P Manes; Ryan S Mackie; Bradford Gutting; Dhritiman V Mukherjee; Taissia G Popova; Fatah Kashanchi; Charles L Bailey; Serguei G Popov
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

8.  Decoy plasminogen receptor containing a selective Kunitz-inhibitory domain.

Authors:  Yogesh Kumar; Kanagasabai Vadivel; Amy E Schmidt; Godwin I Ogueli; Sathya M Ponnuraj; Nalaka Rannulu; Joseph A Loo; Madhu S Bajaj; S Paul Bajaj
Journal:  Biochemistry       Date:  2014-01-13       Impact factor: 3.162

9.  Isolation of a Novel Metalloproteinase from Agkistrodon Venom and Its Antithrombotic Activity Analysis.

Authors:  Jin Huang; Hui Fan; Xiaojian Yin; Fang Huang
Journal:  Int J Mol Sci       Date:  2019-08-21       Impact factor: 5.923

10.  A novel serine protease secreted by medicinal maggots enhances plasminogen activator-induced fibrinolysis.

Authors:  Mariena J A van der Plas; Anders S Andersen; Sheresma Nazir; Nico H van Tilburg; Peter R Oestergaard; Karen A Krogfelt; Jaap T van Dissel; Paul J Hensbergen; Rogier M Bertina; Peter H Nibbering
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.